A World Class Opportunity
Proteomics International is recruiting a visionary Chief Executive Officer to lead a world class, ASX-listed life sciences innovator through its next phase of global growth.
Now is the pivotal moment to build on scientific breakthrough and commercial momentum—especially with major U.S. market launches on the horizon, and shape the future of precision diagnostics for patients worldwide.
Lead the Future of Diagnostics
Are you an accomplished leader ready to scale breakthrough innovation?
Proteomics International Laboratories Ltd (ASX: PIQ) is at an inflection point, driven by industry-defining advances in proteomics and precision medicine.
The Board seeks an inspiring CEO to accelerate commercialisation, drive strategic international partnerships, and represent an ambitious, purpose-driven organisation at the highest levels.
Why Proteomics International?
01
Impact
Transform healthcare globally through award winning diagnostic technologies, including PromarkerD and a fast-growing diagnostics pipeline.
02
Scale
Play a leading role in U.S. market entry and established partnerships across Europe, Asia, and the Americas
03
Resources
Take the reins at a well capitalised company supported by a sophisticated, diverse Board and proven executive team.
04
Culture
Join a collaborative, innovation driven environment that values leadership, integrity, and strategic agility.
The Opportunity
Position
Chief Executive Officer (ASX: PIQ)
Remuneration
Market-leading salary plus significant equity package.
Location
Western Australia (relocation support provided)
Start Date
Targeted for March 2026
Download the Candidate Information Pack
Get full details on the company, team, strategic direction, and the qualities sought in Proteomics International’s next CEO. Discover why this role offers an exceptional career opportunity in diagnostics leadership.
